ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Unveils Checklist for Omics Studies

February 7, 2013

NCI Expects Improved Communications to Result from Consolidation of Offices

May 12, 2000

Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma

November 29, 2002

Major League Baseball Begins Struggle to Eject Ever-Present Smokeless Tobacco Forom The Sport

April 12, 1991

Congress to hold hearings on NIH ethics, Zerhouni pledges greater transparency.

January 9, 2004

NCAB Subcommittee Calls For Review Of Organ Site Program, Consideration Of One For Lung Cancer

May 1, 1981